|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000123191 |
Summary for ATP7B |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000123191 | Gene symbol | ATP7B |
| Gene name | ATPase copper transporting beta | |
| HGNC | 870 | |
| Entrez ID | 540 | |
| Gene type | protein_coding | |
| Synonyms | ATP7B| | |
| UniProtAcc | P35670 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ATP7B |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ATP7B | 8.15e+02 | -2.01e+00 | 4.49e-01 | -4.48e+00 | 7.58e-06 | 4.40e-05 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ATP7B | 1.58e+03 | 1.05e+00 | 1.24e-01 | 8.54e+00 | 1.39e-17 | 4.26e-17 | BRCA |
| ATP7B | 1.53e+03 | 1.51e+00 | 3.62e-01 | 4.17e+00 | 3.00e-05 | 1.69e-04 | READ |
Top |
Sex-biased somatic mutation for ATP7B |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ATP7B |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| CHOL | cg02071074 | chr13:52011147 | CGI:chr13:52011178-52012431 | promoter,gene body | 3.18e-01 | 1.92e-01 | 2.48e+00 | 1.30e-02 | 2.54e-02 | 1.26e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for ATP7B |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ATP7B |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ATP7B |
| TFs related to ATP7B. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ATP7B related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ATP7B |
| RBPs related to ES in ATP7B. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ATP7B related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs56890737 | chr13:54873143:C:T | - | 0.230078738964583 | 0.0456591049395819 | READ | Female-baised eQTL |
| rs9597057 | chr13:54883698:A:G | - | 0.230078738964583 | 0.0456591049395819 | READ | Female-baised eQTL |
| rs11616335 | chr13:45928877:A:T | - | 0.180415011101425 | 4.30372097906113e-05 | LUSC | Female-baised eQTL |
| rs7323013 | chr13:47647854:A:G | - | 0.157425721458791 | 5.60773634444837e-05 | LUSC | Female-baised eQTL |
| rs10220099 | chr13:47895959:C:T | - | 0.138581903631729 | 0.000439215045930754 | LUSC | Female-baised eQTL |
| rs28628659 | chr13:47893051:G:C | - | 0.131000160610329 | 0.00105904410492331 | LUSC | Female-baised eQTL |
| rs76736208 | chr13:47894699:C:T | - | 0.131000160610329 | 0.00105904410492331 | LUSC | Female-baised eQTL |
| rs113930354 | chr13:47898569:G:A | - | 0.130394814124722 | 0.00210207077779268 | LUSC | Female-baised eQTL |
| rs112665619 | chr13:47898617:C:A | - | 0.130394814124722 | 0.00210207077779268 | LUSC | Female-baised eQTL |
| rs79062405 | chr13:47863216:C:T | - | 0.142777384818916 | 0.00213130873685018 | LUSC | Female-baised eQTL |
| rs6561409 | chr13:47891967:A:G | - | -0.136967375030375 | 0.00216670266427672 | LUSC | Female-baised eQTL |
| rs117751234 | chr13:47898799:T:C | - | 0.129223838688091 | 0.00255811734822739 | LUSC | Female-baised eQTL |
| rs114032724 | chr13:48141642:G:A | - | 0.119640841178942 | 0.00390240531943159 | LUSC | Female-baised eQTL |
| rs76139424 | chr13:48144514:A:C | - | 0.12296709989337 | 0.00704327694510451 | LUSC | Female-baised eQTL |
| rs9534251 | chr13:45926160:C:T | - | 0.115462956794253 | 0.00963168119705315 | LUSC | Female-baised eQTL |
| rs112391527 | chr13:47729811:A:G | - | 0.120456682957863 | 0.010298341277768 | LUSC | Female-baised eQTL |
| rs58383714 | chr13:53222727:G:C | - | 0.129957350057587 | 0.0110612260535381 | LUSC | Female-baised eQTL |
| rs116936607 | chr13:53225079:G:A | - | 0.129957350057587 | 0.0110612260535381 | LUSC | Female-baised eQTL |
| rs79170238 | chr13:53227001:A:G | - | 0.129957350057587 | 0.0110612260535381 | LUSC | Female-baised eQTL |
| rs9595762 | chr13:47690505:C:A | - | 0.124337654947964 | 0.0114807180809327 | LUSC | Female-baised eQTL |
| rs117342437 | chr13:53228045:G:A | - | 0.129632411433343 | 0.0115628118709778 | LUSC | Female-baised eQTL |
| rs75415660 | chr13:51105439:A:G | - | 0.111780885657277 | 0.0171024702716402 | LUSC | Female-baised eQTL |
| rs148652785 | chr13:60801928:T:C | - | 0.109187158023102 | 0.018262704957175 | LUSC | Female-baised eQTL |
| rs9568518 | chr13:51111405:C:T | - | 0.111337739723997 | 0.0184365670906561 | LUSC | Female-baised eQTL |
| rs77343871 | chr13:48140496:G:A | - | 0.102529706048356 | 0.0218133501937821 | LUSC | Female-baised eQTL |
| rs77584867 | chr13:48136078:T:C | - | 0.107833759758966 | 0.0241208464553342 | LUSC | Female-baised eQTL |
| rs9538925 | chr13:60798067:T:G | - | 0.104699760708394 | 0.0251980757349346 | LUSC | Female-baised eQTL |
| rs147024443 | chr13:60804387:G:T | - | 0.104699760708394 | 0.0251980757349346 | LUSC | Female-baised eQTL |
| rs9538935 | chr13:60805147:C:T | - | 0.104699760708394 | 0.0251980757349346 | LUSC | Female-baised eQTL |
| rs9538937 | chr13:60805584:G:A | - | 0.104699760708394 | 0.0251980757349346 | LUSC | Female-baised eQTL |
| rs9528230 | chr13:60809561:G:A | - | 0.104699760708394 | 0.0251980757349346 | LUSC | Female-baised eQTL |
| rs35546838 | chr13:60816958:G:A | - | 0.101460857609996 | 0.0303217850772207 | LUSC | Female-baised eQTL |
| rs368161889 | chr13:60803680:A:T | - | 0.100624045747899 | 0.0342456743340227 | LUSC | Female-baised eQTL |
| rs1399148 | chr13:60806281:C:T | - | 0.100624045747899 | 0.0342456743340227 | LUSC | Female-baised eQTL |
| rs9528229 | chr13:60808190:A:T | - | 0.100624045747899 | 0.0342456743340227 | LUSC | Female-baised eQTL |
| rs7319052 | chr13:60808915:C:T | - | 0.100624045747899 | 0.0342456743340227 | LUSC | Female-baised eQTL |
| rs7319710 | chr13:60809081:G:A | - | 0.100624045747899 | 0.0342456743340227 | LUSC | Female-baised eQTL |
| rs115145695 | chr13:42071727:C:T | - | 0.124885064551586 | 0.0382203279571361 | LUSC | Female-baised eQTL |
| rs79306063 | chr13:48031295:T:C | - | 0.0983164543604559 | 0.0488218394056814 | LUSC | Female-baised eQTL |
| rs146928846 | chr13:48034375:G:A | - | 0.0983164543604559 | 0.0488218394056814 | LUSC | Female-baised eQTL |
| rs183651030 | chr13:48039820:A:C | - | 0.0983164543604559 | 0.0488218394056814 | LUSC | Female-baised eQTL |
| rs77321164 | chr13:48040075:G:T | - | 0.0983164543604559 | 0.0488218394056814 | LUSC | Female-baised eQTL |
| rs10507604 | chr13:55994753:G:C | - | 0.123847844629551 | 0.0135455593691009 | STAD | Female-baised eQTL |
| rs74238280 | chr13:52667586:T:A | - | 0.1279636782759 | 0.0356810375070086 | STAD | Female-baised eQTL |
| rs9596668 | chr13:52675862:T:C | - | 0.1279636782759 | 0.0356810375070086 | STAD | Female-baised eQTL |
| rs111380009 | chr13:52686899:C:G | - | 0.1279636782759 | 0.0356810375070086 | STAD | Female-baised eQTL |
| rs113905692 | chr13:52696358:C:T | - | 0.1279636782759 | 0.0356810375070086 | STAD | Female-baised eQTL |
| rs113285106 | chr13:52713615:A:G | - | 0.127916663472068 | 0.0358867440023775 | STAD | Female-baised eQTL |
| rs60755033 | chr13:61519563:A:G | - | 0.0852575760556771 | 0.0395857707284235 | STAD | Female-baised eQTL |
| rs80190915 | chr13:51203776:G:A | - | 0.178376846903193 | 0.0114245861996838 | BLCA | Female-baised eQTL |
| rs77269226 | chr13:51212599:T:A | - | 0.178376846903193 | 0.0114245861996838 | BLCA | Female-baised eQTL |
| rs77339963 | chr13:58971390:C:A | - | 0.0993253872089053 | 0.0145658815436044 | LUAD | Female-baised eQTL |
| rs17055774 | chr13:58966442:T:C | - | 0.0989326466288644 | 0.0152802203526476 | LUAD | Female-baised eQTL |
| rs68086859 | chr13:61198739:T:C | - | 0.0964982101543934 | 0.0153112477137223 | LUAD | Female-baised eQTL |
| rs57042574 | chr13:48716125:A:T | - | 0.084004710979683 | 0.0167704847656804 | LUAD | Female-baised eQTL |
| rs11148326 | chr13:55074978:T:G | - | 0.0503841870211899 | 0.0208900577691855 | LUAD | Female-baised eQTL |
| rs7140122 | chr13:55076714:A:G | - | 0.0503841870211899 | 0.0208900577691855 | LUAD | Female-baised eQTL |
| rs9595978 | chr13:48723933:G:A | - | 0.0677067694278664 | 0.0242961568367522 | LUAD | Female-baised eQTL |
| rs9595990 | chr13:48749928:C:T | - | 0.0664602195584567 | 0.0246457556574153 | LUAD | Female-baised eQTL |
| rs17055784 | chr13:58972420:C:G | - | 0.0934848729404237 | 0.0249584050903772 | LUAD | Female-baised eQTL |
| rs60424010 | chr13:48720446:G:A | - | 0.0738201852531215 | 0.0413244067512232 | LUAD | Female-baised eQTL |
| rs12877713 | chr13:47558599:T:C | - | -0.0586918668749652 | 0.0385193588962709 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7338471 | chr13:49406928:G:T | - | -0.0981557453509488 | 0.045950557778118 | READ | Male-baised eQTL |
| rs9563883 | chr13:61140131:A:G | - | 0.154492991443693 | 0.0180940617599334 | LIHC | Male-baised eQTL |
| rs9563884 | chr13:61145868:C:A | - | 0.154492991443693 | 0.0180940617599334 | LIHC | Male-baised eQTL |
| rs9563890 | chr13:61155577:A:G | - | 0.151598018539144 | 0.0197758643018281 | LIHC | Male-baised eQTL |
| rs9570479 | chr13:61148214:G:A | - | 0.151354299707659 | 0.0202885317617091 | LIHC | Male-baised eQTL |
| rs9563888 | chr13:61149275:G:A | - | 0.151354299707659 | 0.0202885317617091 | LIHC | Male-baised eQTL |
| rs9570480 | chr13:61149867:A:C | - | 0.151354299707659 | 0.0202885317617091 | LIHC | Male-baised eQTL |
| rs75771344 | chr13:61098265:T:G | - | 0.134241144644084 | 0.0212688873520312 | LIHC | Male-baised eQTL |
| rs77557914 | chr13:61098183:T:C | - | 0.131285382804879 | 0.0310660703580528 | LIHC | Male-baised eQTL |
| rs75060974 | chr13:61098237:A:G | - | 0.131285382804879 | 0.0310660703580528 | LIHC | Male-baised eQTL |
| rs79032692 | chr13:50805838:G:T | - | 0.0910836390286617 | 0.0415223577191312 | LIHC | Male-baised eQTL |
| rs76567290 | chr13:50805839:G:A | - | 0.0910836390286617 | 0.0415223577191312 | LIHC | Male-baised eQTL |
| rs77948889 | chr13:50805840:G:T | - | 0.0910836390286617 | 0.0415223577191312 | LIHC | Male-baised eQTL |
| rs7325310 | chr13:50805987:T:C | - | 0.0910836390286617 | 0.0415223577191312 | LIHC | Male-baised eQTL |
| rs9570488 | chr13:61169404:G:A | - | 0.141515226749492 | 0.0439886596473842 | LIHC | Male-baised eQTL |
| rs9535488 | chr13:50806377:G:A | - | 0.09058463885634 | 0.0440448684065447 | LIHC | Male-baised eQTL |
| rs7988749 | chr13:61120815:T:C | - | 0.119626636577656 | 0.0498529126954504 | LIHC | Male-baised eQTL |
| rs759960 | chr13:45872969:A:G | - | 0.0459758163364602 | 0.000614842693833966 | LUSC | Male-baised eQTL |
| rs759963 | chr13:45871874:G:T | - | 0.0399250004183482 | 0.00195098253260535 | LUSC | Male-baised eQTL |
| rs9534246 | chr13:45872292:C:T | - | 0.0399250004183482 | 0.00195098253260535 | LUSC | Male-baised eQTL |
| rs759962 | chr13:45871943:C:G | - | 0.037994666768972 | 0.004033082977097 | LUSC | Male-baised eQTL |
| rs80125013 | chr13:52645944:C:T | - | 0.0416783927575635 | 0.0122072519806905 | LUSC | Male-baised eQTL |
| rs71437879 | chr13:52648493:C:T | - | 0.0416783927575635 | 0.0122072519806905 | LUSC | Male-baised eQTL |
| rs117841366 | chr13:52068864:G:A | - | 0.0434527361242918 | 0.015811006100925 | LUSC | Male-baised eQTL |
| rs118011133 | chr13:52061198:T:C | - | 0.0417760380105745 | 0.0220841866280687 | LUSC | Male-baised eQTL |
| rs9567401 | chr13:44285941:T:C | - | 0.0396300879127169 | 0.0363945583356578 | LUSC | Male-baised eQTL |
| rs73210047 | chr13:60589674:G:A | - | 0.0373783472996121 | 0.0429096156635063 | BLCA | Male-baised eQTL |
| rs9570619 | chr13:61746940:A:G | - | 0.0274535960359245 | 0.0449488544006646 | BLCA | Male-baised eQTL |
| rs9536455 | chr13:53542940:G:T | - | 0.114912114618564 | 0.00199153055839533 | COAD | Male-baised eQTL |
| rs9527145 | chr13:53923816:A:C | - | 0.106046233442317 | 0.00849080175866611 | COAD | Male-baised eQTL |
| rs17461155 | chr13:43732906:C:T | - | 0.107486733540645 | 0.0116383419659505 | COAD | Male-baised eQTL |
| rs2166626 | chr13:42012256:C:G | - | -0.0844345662278933 | 0.0122547262289795 | COAD | Male-baised eQTL |
| rs35426640 | chr13:54091930:T:C | - | 0.0606873502871454 | 0.0125908904470606 | COAD | Male-baised eQTL |
| rs2408989 | chr13:54092753:A:C | - | 0.0579603671064717 | 0.0188722971743125 | COAD | Male-baised eQTL |
| rs7337284 | chr13:53492179:C:T | - | 0.0518982742019615 | 0.0249939269629714 | COAD | Male-baised eQTL |
| rs9527009 | chr13:52788100:G:A | - | 0.0500527287793812 | 0.0370910526878036 | COAD | Male-baised eQTL |
| rs1105586 | chr13:43658497:T:C | - | 0.0475631209827199 | 0.0383730090921513 | COAD | Male-baised eQTL |
| rs9525817 | chr13:43651053:T:C | - | 0.0536338968537307 | 0.038506004130627 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000123191 |
| CpG Site: cg12178900 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.358402340098607 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg12178900 | chr13:51998633 | gene | -0.358402340098607 | 1.86046818735179e-05 | -0.3475992444804271 | 1.3499764423159753e-08 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ATP7B |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000123191 | ATP7B | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0007097 | Carcinoma | 2 | CTD_human |
| ENSG00000123191 | ATP7B | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0015695 | Fatty Liver | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0019158 | Hepatitis | 2 | CTD_human |
| ENSG00000123191 | ATP7B | C0019202 | Hepatolenticular Degeneration | 51 | CTD_human |
| ENSG00000123191 | ATP7B | C0019207 | Hepatoma, Morris | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0019208 | Hepatoma, Novikoff | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0021368 | Inflammation | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0022665 | Kidney Neoplasm | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0023895 | Liver diseases | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0023903 | Liver neoplasms | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0026640 | Mouth Neoplasms | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0041696 | Unipolar Depression | 1 | PSYGENET |
| ENSG00000123191 | ATP7B | C0086404 | Experimental Hepatoma | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0086565 | Liver Dysfunction | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0153381 | Malignant neoplasm of mouth | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0162557 | Liver Failure, Acute | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0205696 | Anaplastic carcinoma | 2 | CTD_human |
| ENSG00000123191 | ATP7B | C0205697 | Carcinoma, Spindle-Cell | 2 | CTD_human |
| ENSG00000123191 | ATP7B | C0205698 | Undifferentiated carcinoma | 2 | CTD_human |
| ENSG00000123191 | ATP7B | C0205699 | Carcinomatosis | 2 | CTD_human |
| ENSG00000123191 | ATP7B | C0235874 | Disease Exacerbation | 3 | CTD_human |
| ENSG00000123191 | ATP7B | C0239946 | Fibrosis, Liver | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0242339 | Dyslipidemias | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0598784 | Dyslipoproteinemias | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0678222 | Breast Carcinoma | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C0919267 | ovarian neoplasm | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C1168401 | Squamous cell carcinoma of the head and neck | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C1269683 | Major Depressive Disorder | 1 | PSYGENET |
| ENSG00000123191 | ATP7B | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C1527352 | Hepatic Form of Wilson Disease | 51 | CTD_human |
| ENSG00000123191 | ATP7B | C2711227 | Steatohepatitis | 1 | CTD_human |
| ENSG00000123191 | ATP7B | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
